Yoshinori Kato Selected Research

albumin-(gadolinium-DTPA)

4/2014	Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.
1/2014	Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Kato Research Topics

Disease

23	Neoplasms (Cancer) 07/2022 - 04/2002
8	Breast Neoplasms (Breast Cancer) 04/2016 - 12/2005
3	Brain Neoplasms (Brain Tumor) 01/2018 - 01/2010
3	Neoplasm Metastasis (Metastasis) 10/2015 - 04/2002
2	Brain Injuries (Brain Injury) 01/2016 - 09/2015
2	Liver Neoplasms (Liver Cancer) 01/2016 - 04/2002
1	Hypoxia (Hypoxemia) 07/2022
1	Hepatitis C 08/2019
1	Triple Negative Breast Neoplasms 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Hemorrhage 01/2016
1	Infections 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Hypersensitivity (Allergy) 01/2014
1	Cold Hypersensitivity 01/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 04/2013
1	Oncogene Addiction 04/2013
1	Hyperglycemia 12/2012
1	Heart Diseases (Heart Disease) 12/2011
1	Myocardial Infarction 12/2011
1	Weight Gain 01/2011
1	Schizophrenia (Dementia Praecox) 01/2011
1	Leukemia 01/2005
1	Neoplasm Micrometastasis 05/2004
1	Stomach Neoplasms (Stomach Cancer) 05/2004
1	Sarcoma (Soft Tissue Sarcoma) 02/2004
1	Wounds and Injuries (Trauma) 10/2003
1	Hepatocellular Carcinoma (Hepatoma) 09/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2005
6	Pharmaceutical PreparationsIBA 04/2016 - 01/2005
4	Contrast MediaIBA 11/2015 - 04/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 12/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2014 - 01/2014
3	Drug CarriersIBA 01/2011 - 10/2003
3	Antineoplastic Agents (Antineoplastics)IBA 01/2010 - 01/2005
3	Temozolomide (Temodar)FDA LinkGeneric 01/2010 - 04/2006
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2003 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 04/2016 - 02/2014
2	geldanamycinIBA 01/2016 - 04/2013
2	Molecular Chaperones (Chaperone, Molecular)IBA 01/2016 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 12/2012
2	albumin-(gadolinium-DTPA)IBA 04/2014 - 01/2014
2	Bevacizumab (Avastin)FDA Link 04/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 06/2007
2	SugarsIBA 12/2012 - 02/2004
2	GadoliniumIBA 01/2010 - 04/2006
2	ChitosanIBA 01/2005 - 10/2003
2	ChitinIBA 01/2005 - 10/2003
2	N-succinyl-chitosanIBA 10/2003 - 04/2002
1	Biological ProductsIBA 07/2022
1	ombitasvirIBA 08/2019
1	Ritonavir (Norvir)FDA Link 08/2019
1	dasabuvirIBA 08/2019
1	paritaprevirIBA 08/2019
1	Cytochrome P-450 CYP3AIBA 08/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2019
1	CytokinesIBA 01/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	ferric oxide (iron oxide)IBA 01/2016
1	myosin light chain 2IBA 01/2016
1	STA 9090IBA 01/2016
1	Linezolid (Zyvox)FDA Link 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	Liposomes (Liposome)IBA 11/2015
1	NucleosidesIBA 10/2015
1	RNA Helicases (RNA Helicase)IBA 10/2015
1	Small Interfering RNA (siRNA)IBA 10/2015
1	Monoclonal AntibodiesIBA 02/2014
1	AzidesIBA 02/2014
1	AlbuminsIBA 02/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014
1	AnkyrinsIBA 01/2014
1	gosha-jinki-ganIBA 01/2014
1	Ion Channels (Ion Channel)IBA 01/2014
1	Basic Helix-Loop-Helix Transcription FactorsIBA 11/2013
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 04/2013
1	Protons (Proton)IBA 12/2012
1	Hydroxyl RadicalIBA 12/2012
1	TenascinIBA 12/2011
1	Single-Chain AntibodiesIBA 12/2011
1	Antipsychotic Agents (Antipsychotics)IBA 01/2011
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011
1	AcidsIBA 01/2010
1	vitamin B 12 factor III (HMQC)IBA 01/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2007
1	doxifluridineIBA 01/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005
1	Floxuridine (FUdR)FDA LinkGeneric 05/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2002
1	ZinostatinIBA 05/2002

Therapy/Procedure

12	Therapeutics 01/2017 - 12/2007
5	Drug Therapy (Chemotherapy) 02/2014 - 10/2003
2	Radiotherapy 01/2016 - 01/2016
2	Intravenous Administration 11/2015 - 02/2004
1	Immunotherapy 01/2018